KNOWN EFFECTS OF TREATMENT WITH HMG-COA REDUCTASE INHIBITORS (CHOLESTEROL-SYNTHESIS INHIBITORS)

被引:0
|
作者
KNISEL, W
EGGSTEIN, M
机构
来源
INTERNIST | 1989年 / 30卷 / 12期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:776 / 783
页数:8
相关论文
共 50 条
  • [31] HMG-CoA Reductase Inhibitors and Myotoxicity
    Memduh Ucar
    Tom Mjörndal
    Rune Dahlqvist
    Drug Safety, 2000, 22 : 441 - 457
  • [32] HMG-CoA reductase inhibitors and myotoxicity
    Ucar, M
    Mjörndal, T
    Dahlqvist, R
    DRUG SAFETY, 2000, 22 (06) : 441 - 457
  • [33] Rhabdomyolysis and HMG-CoA reductase inhibitors
    Omar, MA
    Wilson, JP
    Cox, TS
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (09) : 1096 - 1107
  • [34] HMG-CoA reductase inhibitors for the treatment of pancreatic cancer
    Schmid, RM
    GASTROENTEROLOGY, 2002, 122 (02) : 565 - 567
  • [35] Myopathy secondary to the treatment with inhibitors of HMG-CoA reductase
    Fuentes, I
    Aguilera, C
    MEDICINA CLINICA, 1998, 111 (18): : 700 - 700
  • [36] Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors
    Duplaga, BA
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (11) : 1224 - 1227
  • [37] PERINATAL-DEVELOPMENT OF CHOLESTEROL-SYNTHESIS AND HMG-COA REDUCTASE REGULATION
    LEONI, S
    MANGIANTINI, MT
    SPAGNUOLO, S
    DEVIRGILIIS, LC
    VALBONESI, M
    TRENTALANCE, A
    JOURNAL OF LIPID RESEARCH, 1986, 27 (05) : 564 - 565
  • [38] Direct vascular effects of HMG-CoA reductase inhibitors
    Laufs, U
    Liao, JK
    TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (04) : 143 - 148
  • [39] Direct vascular effects of HMG-CoA reductase inhibitors
    Corsini, A
    Soma, MR
    Pfister, P
    Paoletti, R
    Pazzucconi, F
    Sirtori, CR
    Fumagalli, R
    Bernini, F
    ATHEROSCLEROSIS, 1997, 130 : 85 - 85
  • [40] Immunosuppressive and antiproliferative effects of HMG-CoA reductase inhibitors
    Katznelson, S
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (3B) : 22S - 24S